縮宮素+麥角新堿對剖宮產產后出血治療效果及紅細胞壓積、血紅蛋白指標探究

打開文本圖片集

【摘要】目的：探究縮宮素聯(lián)合麥角新堿對剖宮產產后出血治療效果及對紅細胞壓積、血紅蛋白指標的影響。方法：2018年9月—2021年9月，從本院收治的剖宮產產后出血患者中選擇68例，利用隨機數(shù)表法分兩組，各34例，對照組接受縮宮素治療，試驗組接受縮宮素聯(lián)合麥角新堿治療，比較兩組治療情況。結果：試驗組治療總有效率為97.06%，對照組為79.41%，試驗組高于對照組（P0.05）；治療后，兩組患者RBC、HCT、Hb 均高于治療前（P

【關鍵詞】剖宮產；產后出血；縮宮素；麥角新堿；血常規(guī)

Study on the therapeutic effect of oxytocin combined with ergometrine on postpartum hemorrhage after cesarean section and the indexes of hematocrit and hemoglobin

LI Yao

Heshui County People’s Hospital， Qingyang， Gansu 745400， China

【Abstract】Objective： To explore the therapeutic effect of oxytocin combined with ergometrine on postpartum hemorrhage after cesarean section and the effect on hematocrit and hemoglobin indexes. Methods： From September 2018 to September 2021， 68 patients with postpartum hemorrhage after cesarean section admitted to our hospital were selected and divided into two groups by random number table method， with 34 cases in each group. The control group received oxytocin therapy， while the experimental group received oxytocin combined with ergometrine therapy. The treatment conditions of the two groups were compared. Results： The total effective rate was 97.06% in the experimental group and 79.41% in the control group. The experimental group was higher than the control group（P0.05）. After treatment， the RBC， HCT and Hb of the two groups were higher than those before treatment（P

【Key Words】Cesarean section； Postpartum hemorrhage； Oxytocin； Ergometrine； Blood routine

產后出血是產科常見并發(fā)癥之一，也是導致產婦死亡的主要原因，具體發(fā)病與宮縮乏力、軟產道撕裂、胎盤因素和凝血功能障礙等因素有關，其中宮縮乏力為主要誘因，很多剖宮產患者受宮縮乏力影響，容易出現(xiàn)產后出血情況[1-2]。（剩余4339字）